Literature DB >> 7972015

Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator.

F Hofer1, S Fields, C Schneider, G S Martin.   

Abstract

The yeast two-hybrid system was used to identify proteins that interact with Ras. The H-Ras protein was found to interact with a guanine nucleotide dissociation stimulator (GDS) that has been previously shown to regulate guanine nucleotide exchange on another member of the Ras protein family, Ral. The interaction is mediated by the C-terminal, noncatalytic segment of the RalGDS and can be detected both in vivo, using the two-hybrid system, and in vitro, with purified recombinant proteins. The interaction of the RalGDS C-terminal segment with Ras is specific, dependent on activation of Ras by GTP, and blocked by a mutation that affects Ras effector function. These characteristics are similar to those previously demonstrated for the interaction between Ras and its putative effector, Raf, suggesting that the RalGDS may also be a Ras effector. Consistent with this idea, the RalGDS was found to inhibit the binding of Raf to Ras.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972015      PMCID: PMC45172          DOI: 10.1073/pnas.91.23.11089

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest.

Authors:  C T Chien; P L Bartel; R Sternglanz; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 2.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Mutations of the adenylyl cyclase gene that block RAS function in Saccharomyces cerevisiae.

Authors:  J Field; H P Xu; T Michaeli; R Ballester; P Sass; M Wigler; J Colicelli
Journal:  Science       Date:  1990-01-26       Impact factor: 47.728

4.  Functional homology of mammalian and yeast RAS genes.

Authors:  T Kataoka; S Powers; S Cameron; O Fasano; M Goldfarb; J Broach; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

5.  In yeast, RAS proteins are controlling elements of adenylate cyclase.

Authors:  T Toda; I Uno; T Ishikawa; S Powers; T Kataoka; D Broek; S Cameron; J Broach; K Matsumoto; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

6.  The C-terminal part of the CDC25 gene product plays a key role in signal transduction in the glucose-induced modulation of cAMP level in Saccharomyces cerevisiae.

Authors:  L Van Aelst; E Boy-Marcotte; J H Camonis; J M Thevelein; M Jacquet
Journal:  Eur J Biochem       Date:  1990-11-13

7.  Comparison of thermosensitive alleles of the CDC25 gene involved in the cAMP metabolism of Saccharomyces cerevisiae.

Authors:  A Petitjean; F Hilger; K Tatchell
Journal:  Genetics       Date:  1990-04       Impact factor: 4.562

8.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

9.  High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.

Authors:  R H Schiestl; R D Gietz
Journal:  Curr Genet       Date:  1989-12       Impact factor: 3.886

10.  Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae.

Authors:  S Powers; K O'Neill; M Wigler
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

View more
  77 in total

1.  Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells.

Authors:  S Sarner; R Kozma; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Structure characterization of human RalGDS gene, and the identification of its novel variant.

Authors:  Q Zheng; L Yu; Y Zhao; H Zhang; Q Fu; N Mao; P Hu; Z Geng; S Zhao
Journal:  Mol Biol Rep       Date:  2000       Impact factor: 2.316

3.  Activation of CD4 T cells by Raf-independent effectors of Ras.

Authors:  Jan Czyzyk; Jennifer L Brogdon; Abdallah Badou; Octavian Henegariu; Paula Preston Hurlburt; Richard Flavell; Kim Bottomly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

4.  Ral GTPase and the exocyst regulate autophagy in a tissue-specific manner.

Authors:  Kirsten Tracy; Panagiotis D Velentzas; Eric H Baehrecke
Journal:  EMBO Rep       Date:  2015-11-23       Impact factor: 8.807

5.  H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.

Authors:  Takahisa Matsuda; Jae Im Jeong; Shohei Ikeda; Takanobu Yamamoto; Shumin Gao; Gopal J Babu; Peiyong Zhai; Dominic P Del Re
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

Review 6.  All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.

Authors:  J L Bos
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

7.  Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.

Authors:  G J Clark; J K Drugan; R S Terrell; C Bradham; C J Der; R M Bell; S Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis.

Authors:  I Treinies; H F Paterson; S Hooper; R Wilson; C J Marshall
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 9.  Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.

Authors:  M Spaargaren; J R Bischoff; F McCormick
Journal:  Gene Expr       Date:  1995

Review 10.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.